| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в лютому 1991 (uk)
- article scientifique publié en 1991 (fr)
- im Februar 1991 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en febreru de 1991 (ast)
- artikull shkencor i botuar më 01 shkurt 1991 (sq)
- scientific article published on 01 February 1991 (en)
|
| publication date
| |
| publication date
| |
| cites work
| |
| cites work
| |
| access restriction status
| |
| access restriction status
| |
| author name string
| |
| author name string
| - H Takahashi
- K Isono
- H Osada
- G Kawanishi
|
| rdfs:label
| - Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor (en)
- Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor (nl)
- Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor (sq)
|
| skos:prefLabel
| - Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor (en)
- Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor (nl)
- Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor (sq)
|
| name
| - Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor (en)
- Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor (nl)
- Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor (sq)
|
| author
| |
| author
| |
| title
| |
| title
| - Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| - Streptomyces
- 10-(9-Butyl-8-(4-carboxy-3-methyl-3-butenyl)-9-((3-carboxypropanoyl)oxy)-3-methyl-1,7-dioxaspiro[5.5]undec-2-yl)-5-hydroxy-4,8-dimethyl-2,6,8-decatrienoic acid
- reveromycin A
- (2E,4R,5R,6E,8E)-10-[(2R,3S,6R,8S,9R)-3-butyl-2-[(1E,3E)-4-carboxy-3-methylbuta-1,3-dienyl]-3-(3-carboxypropanoyloxy)-9-methyl-1,7-dioxaspiro[5.5]undecan-8-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid
|
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| full work available at URL
| |
| published in
| |
| full work available at URL
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.7164/ANTIBIOTICS.44.259
|
| online access status
| |
| online access status
| |
| is about
of | |
| is cites work
of | - Development of a Terpenoid-Production Platform in Streptomyces reveromyceticus SN-593.
- Photo-cross-linked small-molecule microarrays as chemical genomic tools for dissecting protein-ligand interactions.
- Understanding and controlling the cell cycle with natural products
- Reveromycin A biosynthesis uses RevG and RevJ for stereospecific spiroacetal formation.
- Biochemical characterization of a novel indole prenyltransferase from Streptomyces sp. SN-593
- Spirofungin, a new antifungal antibiotic from Streptomyces violaceusniger Tü 4113.
- Identification of marine organism extracts active at the EGF binding site of human A431 cells
- Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages
- Nonanomeric spiroketals in natural products: structures, sources, and synthetic strategies
- Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts
- Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities
- Reveromycin A inhibits antigen receptor-mediated antigen presentation by B lymphoma cells via its effect on intracellular trafficking of the antigen.
- Reveromycins, new inhibitors of eukaryotic cell growth. I. Producing organism, fermentation, isolation and physico-chemical properties
- Construction of a microbial natural product library for chemical biology studies
- Determination of interconversion barriers by dynamic gas chromatography: epimerization of chalcogran
- Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease
- Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases
- Spirotoamides A and B, novel 6,6-spiroacetal polyketides isolated from a microbial metabolite fraction library
- RK-1355A and B, novel quinomycin derivatives isolated from a microbial metabolites fraction library based on NPPlot screening
- Furaquinocins I and J: novel polyketide isoprenoid hybrid compounds from Streptomyces reveromyceticus SN-593
- Morphology reversion activity of phosmidosine and phosmidosine B, a newly isolated derivative, on src transformed NRK cells
- A new cyclic lipopeptide antibiotic, enamidonin
- Morphobase, an encyclopedic cell morphology database, and its use for drug target identification.
- Oxidative Cyclization in Natural Product Biosynthesis
- Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity
- Structure-function analyses of cytochrome P450revI involved in reveromycin A biosynthesis and evaluation of the biological activity of its substrate, reveromycin T.
- Creation of novel reveromycin derivatives by alcohol-added fermentation.
- Effect of Reveromycin A on experimental tooth movement in OPG-/- mice
- Stereoselective total synthesis of reveromycin B and C19-epi-reveromycin B.
- Reveromycins Revealed: New polyketide spiroketals from Australian marine-derived and terrestrial Streptomyces spp. A case of natural products vs. artifacts
- Reveromycins A and B from Streptomyces sp. 3-10: Antifungal Activity against Plant Pathogenic Fungi In vitro and in a Strawberry Food Model System
- QM-HiFSA-Aided Structure Determination of Succinilenes A-D, New Triene Polyols from a Marine-Derived Streptomyces sp.
- Biocontrol of Aspergillus flavus on Peanut Kernels Using Streptomyces yanglinensis 3-10.
- Application of Dess-Martin oxidation in total synthesis of natural products
- Alkyldihydropyrones, new polyketides synthesized by a type III polyketide synthase from Streptomyces reveromyceticus.
- Identification of a molecular target of a novel fungal metabolite, pyrrolizilactone, by phenotypic profiling systems
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)